TROY, Mich., June 5 /PRNewswire-FirstCall/ -- Somanetics Corporation
(Nasdaq: SMTS) will release its financial results for the second quarter ended
May 31, 2008 before the opening of the market on Wednesday, June 18, 2008. In
conjunction with its financial results, the Company will host a conference
call that will be webcast live at 10:00 a.m. (ET) the same day.
On the conference call, Bruce Barrett, Somanetics' president and chief
executive officer, and Bill Iacona, chief financial officer, will review
Somanetics' financial results.
To listen to the webcast, visit the Investor Center page of Somanetics'
website at http://www.somanetics.com 15 minutes prior to the event's broadcast
and click on the "Second Quarter 2008 Conference Call" link. Interested
parties unable to listen to the live call may access the archived version of
the call on the Investor Center page of Somanetics' website for one year after
the call. Windows Media Player is required for access to the webcast and is
available for downloading free of charge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets
the INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive patient
monitoring system that continuously measures changes in the blood oxygen
levels in the brain and elsewhere in the body in patients with or at risk for
restricted blood flow. Surgeons, anesthesiologists and other medical
professionals can use the information provided by the INVOS System, in
conjunction with other available information, to identify oxygen imbalances in
tissues beneath the sensor and take necessary corrective action, potentially
improving patient outcomes and reducing the costs of care. Somanetics
supports its customers through a direct U.S. sales force and clinical
education team. Covidien markets INVOS System products in Europe, Canada, the
Middle East and South Africa and Edwards Lifesciences represents INVOS System
products in Japan. For more information visit http://www.somanetics.com .
SOURCE Somanetics Corporation
